Pulse Biosciences, Inc.
NASDAQ:PLSE
15.19 (USD) • At close November 4, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Pulse Biosciences, Inc. |
Symbool | PLSE |
Munteenheid | USD |
Prijs | 15.19 |
Beurswaarde | 934,438,673 |
Dividendpercentage | 0% |
52-weken bereik | 4.571 - 22.69 |
Industrie | Medical Instruments & Supplies |
Sector | Healthcare |
CEO | Mr. Robert W. Duggan |
Website | https://www.pulsebiosciences.com |
An error occurred while fetching data.
Over Pulse Biosciences, Inc.
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)